Ventyx Biosciences (VTYX) Institutional Ownership $2.46 +0.06 (+2.50%) Closing price 09/2/2025 04:00 PM EasternExtended Trading$2.48 +0.02 (+0.98%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Ventyx Biosciences (NASDAQ:VTYX)CurrentInstitutional OwnershipPercentage97.88%Number ofInstitutional Buyers(last 12 months)68TotalInstitutional Inflows(last 12 months)$48.55MNumber ofInstitutional Sellers(last 12 months)30TotalInstitutional Outflows(last 12 months)$31.21M Get VTYX Insider Trade Alerts Want to know when executives and insiders are buying or selling Ventyx Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data VTYX Institutional Buying and Selling by Quarter Ventyx Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/18/2025 Hudson Bay Capital Management LP15,864$34K0.0%N/A0.022% 8/15/2025 Tower Research Capital LLC TRC 36,834$79K0.0%+337.1%0.052% 8/15/2025 Shay Capital LLC56,619$121K0.0%-78.4%0.079% 8/15/2025 Hudson Bay Capital Management LP15,864$34K0.0%N/A0.022% 8/15/2025 Engineers Gate Manager LP19,517$42K0.0%N/A0.027% 8/15/2025 BNP Paribas Financial Markets14,220$30K0.0%-89.4%0.020% 8/15/2025 Boothbay Fund Management LLC280,413$600K0.0%-20.5%0.393% 8/15/2025 Bridgeway Capital Management LLC53,600$115K0.0%-45.6%0.075% 8/15/2025 Brevan Howard Capital Management LP114,831$246K0.0%N/A0.161% 8/15/2025 Bank of America Corp DE838,387$1.79M0.0%-17.5%1.176% Get the Latest News and Ratings for VTYX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ventyx Biosciences and its competitors with MarketBeat's FREE daily newsletter. 8/15/2025 Ameriprise Financial Inc.28,031$60K0.0%N/A0.039% 8/14/2025 Jane Street Group LLC400,597$857K0.0%+723.7%0.562% 8/14/2025 Redmile Group LLC1,114,529$2.39M0.3%-29.0%1.563% 8/14/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 79,000$169K0.0%N/A0.111% 8/14/2025 Cerity Partners LLC38,386$82K0.0%-21.8%0.054% 8/13/2025 Jump Financial LLC24,956$53K0.0%N/A0.035% 8/13/2025 Affinity Asset Advisors LLC4,536,182$9.71M1.3%N/A6.361% 8/13/2025 Marshall Wace LLP2,396,823$5.13M0.0%N/A3.361% 8/13/2025 Walleye Capital LLC422,094$903K0.0%-16.3%0.592% 8/13/2025 Invesco Ltd.82,642$177K0.0%-29.4%0.116% 8/13/2025 Sio Capital Management LLC1,307,964$2.80M1.1%-49.4%1.834% 8/12/2025 XTX Topco Ltd161,611$346K0.0%+230.1%0.227% 8/12/2025 JPMorgan Chase & Co.457,919$980K0.0%-56.1%0.642% 8/12/2025 Catalyst Funds Management Pty Ltd28,500$61K0.0%N/A0.040% 8/8/2025 Bailard Inc.41,300$88K0.0%N/A0.058% 8/8/2025 Geode Capital Management LLC711,844$1.52M0.0%-51.3%1.000% 8/7/2025 Monaco Asset Management SAM761,891$1.63M0.3%-32.8%1.071% 8/7/2025 Connor Clark & Lunn Investment Management Ltd.945,206$2.02M0.0%+8.4%1.328% 8/6/2025 Prospera Financial Services Inc149,200$319K0.0%N/A0.210% 8/1/2025 Y Intercept Hong Kong Ltd69,236$148K0.0%N/A0.097% 8/1/2025 Ashton Thomas Private Wealth LLC33,374$71K0.0%N/A0.047% 7/25/2025 CWM LLC57,145$122K0.0%+7.6%0.080% 7/25/2025 Vanguard Personalized Indexing Management LLC46,711$100K0.0%+104.1%0.066% 7/10/2025 Wealth Enhancement Advisory Services LLC29,657$62K0.0%+21.1%0.042% 7/9/2025 Pallas Capital Advisors LLC17,824$38K0.0%N/A0.025% 6/27/2025 Goldman Sachs Group Inc.593,248$682K0.0%-60.7%0.834% 5/29/2025 Rhumbline Advisers85,928$99K0.0%-35.3%0.121% 5/21/2025 Acadian Asset Management LLC537,054$614K0.0%+443.8%0.755% 5/19/2025 Jane Street Group LLC48,635$56K0.0%N/A0.068% 5/16/2025 Goldman Sachs Group Inc.593,248$682K0.0%-60.7%0.834% Forget Tesla — This Tiny AI Stock Is Musk’s Real Play (Ad)While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it could transform warfare, robotics, and the global economy. But you don’t need to buy Tesla or wait for xAI to IPO to benefit. One overlooked public company is supplying the critical tech behind Musk’s AI push — and it trades for a fraction of Nvidia’s price. Hedge funds are already loading up, but most investors haven’t noticed yet.See the full details on this “backdoor” Musk bet here5/16/2025 AQR Capital Management LLC880,222$1.01M0.0%+925.6%1.237% 5/16/2025 ADAR1 Capital Management LLC281,600$324K0.1%+126.1%0.396% 5/15/2025 Redmile Group LLC1,569,793$1.81M0.2%+1,164.1%2.206% 5/14/2025 Ieq Capital LLC194,189$223K0.0%N/A0.273% 5/14/2025 Walleye Capital LLC504,245$580K0.0%+5.5%0.709% 5/12/2025 Nuveen LLC168,420$194K0.0%N/A0.237% 5/12/2025 Invesco Ltd.117,062$135K0.0%-19.6%0.165% 5/9/2025 Charles Schwab Investment Management Inc.448,345$516K0.0%-8.3%0.630% 5/8/2025 Monaco Asset Management SAM1,134,444$1.31M0.3%+372.7%1.594% 5/8/2025 XTX Topco Ltd48,951$56K0.0%-50.8%0.069% 5/1/2025 Cutter & CO Brokerage Inc.54,000$62K0.0%N/A0.076% 5/1/2025 CWM LLC53,088$61K0.0%+1,733.8%0.075% 4/30/2025 Cerity Partners LLC49,106$56K0.0%N/A0.069% 4/16/2025 Wealth Enhancement Advisory Services LLC24,483$28K0.0%N/A0.034% 4/8/2025 Rhumbline Advisers85,928$99K0.0%-35.3%0.121% 2/17/2025 Woodline Partners LP213,240$467K0.0%N/A0.302% 2/17/2025 Velan Capital Investment Management LP35,000$77K0.1%N/A0.049% 2/17/2025 Vestal Point Capital LP2,000,000$4.38M0.3%+15.9%2.828% 2/17/2025 Squarepoint Ops LLC62,990$138K0.0%-12.3%0.089% 2/17/2025 Wexford Capital LP398,463$873K0.1%-11.3%0.564% 2/17/2025 Two Sigma Investments LP476,291$1.04M0.0%+79.8%0.674% 2/17/2025 Two Sigma Advisers LP800,800$1.75M0.0%+72.1%1.132% 2/17/2025 Shay Capital LLC124,615$273K0.0%N/A0.176% 2/17/2025 Redmile Group LLC124,178$272K0.0%-94.1%0.176% 2/17/2025 Point72 Asset Management L.P.1,782,007$3.90M0.0%N/A2.520% 2/17/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC244,000$534K0.0%+22.0%0.345% 2/17/2025 Millennium Management LLC1,281,629$2.81M0.0%+369.7%1.812% 2/17/2025 Jacobs Levy Equity Management Inc.479,212$1.05M0.0%-15.7%0.678% 2/17/2025 D. E. Shaw & Co. Inc.52,231$114K0.0%-51.0%0.074% 2/17/2025 Deerfield Management Company L.P. Series C534,737$1.17M0.0%-92.0%0.756% 2/17/2025 Bank of America Corp DE4,273,442$9.36M0.0%+376.4%6.044% 2/17/2025 BNP Paribas Financial Markets126,143$276K0.0%N/A0.178% 2/14/2025 Northern Trust Corp485,664$1.06M0.0%+4.3%0.687% 2/14/2025 Boothbay Fund Management LLC314,891$690K0.0%+472.2%0.445% 2/14/2025 Susquehanna Fundamental Investments LLC198,947$436K0.0%N/A0.281% 2/14/2025 Price T Rowe Associates Inc. MD41,286$91K0.0%-24.8%0.058% 2/14/2025 MetLife Investment Management LLC26,731$59K0.0%+76.0%0.038% 2/14/2025 Dimensional Fund Advisors LP158,288$347K0.0%N/A0.224% 2/13/2025 Walleye Capital LLC477,788$1.05M0.0%+22.5%0.676% 2/13/2025 XTX Topco Ltd99,423$218K0.0%-11.8%0.141% 2/13/2025 Mariner LLC22,105$48K0.0%-27.7%0.031% 2/13/2025 Barclays PLC91,669$200K0.0%+14.2%0.130% 2/13/2025 Renaissance Technologies LLC624,500$1.37M0.0%+99.1%0.883% 2/13/2025 ADAR1 Capital Management LLC124,530$273K0.1%+27.1%0.176% 2/13/2025 Wells Fargo & Company MN41,170$90K0.0%+23.3%0.058% 2/12/2025 Geode Capital Management LLC1,413,039$3.10M0.0%+1.5%1.998% 2/12/2025 JPMorgan Chase & Co.928,589$2.03M0.0%-7.8%1.313% 2/11/2025 AXQ Capital LP13,154$29K0.0%N/A0.019% 2/11/2025 American Century Companies Inc.67,329$147K0.0%+12.4%0.095% 2/11/2025 Virtu Financial LLC86,385$189K0.0%N/A0.122% Buffett, Gates and Bezos Dumping Stocks (Ad)The world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated billions of shares. Bill Gates sold 500,000 shares of Microsoft. Jeff Bezos filed to sell Amazon shares worth $4.8 billion. What is going on? One multi-millionaire believes they are preparing for a catastrophic event. But not a crash, bank run, or recession. It’s something we haven’t see in America for more than a century.For the full story, click here.2/10/2025 Monaco Asset Management SAM240,000$526K0.1%N/A0.339% 2/10/2025 Connor Clark & Lunn Investment Management Ltd.871,527$1.91M0.0%+88.6%1.233% 1/30/2025 Palumbo Wealth Management LLC23,932$52K0.0%+97.1%0.034% 1/30/2025 Rhumbline Advisers132,825$291K0.0%+44.4%0.188% 1/24/2025 Catalina Capital Group LLC11,456$25K0.0%N/A0.016% 1/17/2025 SG Americas Securities LLC25,150$55K0.0%-27.5%0.036% 12/26/2024 JPMorgan Chase & Co.1,007,519$2.20M0.0%+2.0%1.425% 11/19/2024 Barclays PLC80,295$175K0.0%+273.1%0.114% 11/16/2024 Geode Capital Management LLC1,391,702$3.03M0.0%+5.9%1.968% 11/15/2024 Barclays PLC80,295$175K0.0%+273.1%0.114% (Data available from 1/1/2016 forward) VTYX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VTYX shares? During the previous two years, 122 institutional investors and hedge funds held shares of Ventyx Biosciences. The most heavily invested institutionals were FMR LLC ($301.37M), Lord Abbett & CO. LLC ($60.06M), Wellington Management Group LLP ($46.64M), Loomis Sayles & Co. L P ($43.69M), Adage Capital Partners GP L.L.C. ($34.31M), venBio Partners LLC ($26.35M), and Vanguard Group Inc. ($20.38M).Learn more on Ventyx Biosciences' institutional investors. What percentage of Ventyx Biosciences' stock is owned by institutional investors? 97.88% of Ventyx Biosciences' stock is owned by institutional investors. Learn more on VTYX's institutional investor holdings. Which institutional investors have been buying Ventyx Biosciences' stock? Of the 102 institutional investors that purchased Ventyx Biosciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Affinity Asset Advisors LLC ($4.54M), Redmile Group LLC ($3.40M), Bank of America Corp DE ($3.38M), Farallon Capital Management LLC ($3.17M), Marshall Wace LLP ($2.40M), Deerfield Management Company L.P. Series C ($2.29M), and Point72 Asset Management L.P. ($1.78M). How much institutional buying is happening at Ventyx Biosciences? Institutional investors have bought a total of 24,418,533 shares in the last 24 months. This purchase volume represents approximately $48.55M in transactions. Which of Ventyx Biosciences' major shareholders have been selling company stock? Of the 30 institutional investors that sold Ventyx Biosciences' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Deerfield Management Company L.P. Series C ($6.18M), Redmile Group LLC ($2.50M), Goldman Sachs Group Inc. ($1.84M), Sio Capital Management LLC ($1.27M), Geode Capital Management LLC ($751.26K), JPMorgan Chase & Co. ($665.15K), and Monaco Asset Management SAM ($372.55K). How much institutional selling is happening at Ventyx Biosciences? Institutional investors have sold a total of 15,321,841 shares in the last 24 months. This volume of shares sold represents approximately $31.21M in transactions. Related Companies KalVista Pharmaceuticals Institutional Ownership Mind Medicine (MindMed) Institutional Ownership Tyra Biosciences Institutional Ownership Organogenesis Institutional Ownership Bicara Therapeutics Institutional Ownership Rapport Therapeutics Institutional Ownership Maze Therapeutics Institutional Ownership Rezolute Institutional Ownership Relay Therapeutics Institutional Ownership Immatics Institutional Ownership This page (NASDAQ:VTYX) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ventyx Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ventyx Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
